spacer
spacer

PDBsum entry 3fpm

Go to PDB code: 
protein ligands links
Transferase PDB id
3fpm

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
283 a.a. *
Ligands
793
* Residue conservation analysis
PDB id:
3fpm
Name: Transferase
Title: Crystal structure of a squarate inhibitor bound to mapkap kinase-2
Structure: Map kinase-activated protein kinase 2. Chain: a. Fragment: protein kinase domain. Synonym: mapk-activated protein kinase 2, mapkap kinase 2, mapkapk-2, mk2. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: mapkapk2. Expressed in: escherichia coli. Expression_system_taxid: 562.
Resolution:
3.30Å     R-factor:   0.284     R-free:   0.337
Authors: K.D.Parris
Key ref: F.Lovering et al. (2009). Identification and SAR of squarate inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2). Bioorg Med Chem Lett, 17, 3342-3351. PubMed id: 19364658
Date:
05-Jan-09     Release date:   07-Apr-09    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P49137  (MAPK2_HUMAN) -  MAP kinase-activated protein kinase 2 from Homo sapiens
Seq:
Struc:
400 a.a.
283 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.2.7.11.1  - non-specific serine/threonine protein kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction:
1. L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
2. L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
L-seryl-[protein]
+ ATP
= O-phospho-L-seryl-[protein]
+ ADP
+ H(+)
L-threonyl-[protein]
+ ATP
= O-phospho-L-threonyl-[protein]
+ ADP
+ H(+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
Bioorg Med Chem Lett 17:3342-3351 (2009)
PubMed id: 19364658  
 
 
Identification and SAR of squarate inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2).
F.Lovering, S.Kirincich, W.Wang, K.Combs, L.Resnick, J.E.Sabalski, J.Butera, J.Liu, K.Parris, J.B.Telliez.
 
  ABSTRACT  
 
A novel series of inhibitors for mitogen activated protein kinase-activated protein kinase 2 (MK-2) are reported. These squarate based inhibitors were identified via a high-throughput screen. An MK2 co-structure with the starting ligand was obtained and a structure based approach was followed to optimize potency and selectivity.
 

 

spacer

spacer